These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 27566087)
1. Renal Denervation in Patients with Resistant Hypertension-Assessment by 3T Renal 23Na-MRI: Preliminary Results. Budjan J; Benck U; Lammert A; Ong MM; Mircheva M; Diehl S; Konstandin S; Schad LR; Krämer BK; Schoenberg SO; Haneder S In Vivo; 2016 09-10; 30(5):657-62. PubMed ID: 27566087 [TBL] [Abstract][Full Text] [Related]
2. Skin sodium content as a predictor of blood pressure response to renal denervation. Guenes-Altan M; Schmid A; Kannenkeril D; Linz P; Ott C; Bosch A; Schiffer M; Uder M; Schmieder RE Hypertens Res; 2024 Feb; 47(2):361-371. PubMed ID: 37880499 [TBL] [Abstract][Full Text] [Related]
3. Renal denervation: results of a single-center cohort study. Luetkens JA; Wilhelm K; Düsing R; Woitas RP; Thomas D; Hundt F; Doerner J; Schild HH; Nähle CP Rofo; 2015 Jan; 187(1):36-41. PubMed ID: 25188311 [TBL] [Abstract][Full Text] [Related]
4. Limited destruction of renal nerves after catheter-based renal denervation: results of a human case study. Vink EE; Goldschmeding R; Vink A; Weggemans C; Bleijs RL; Blankestijn PJ Nephrol Dial Transplant; 2014 Aug; 29(8):1608-10. PubMed ID: 24875664 [TBL] [Abstract][Full Text] [Related]
5. Effects of renal denervation on end organ damage in hypertensive patients. Verloop WL; Vink EE; Spiering W; Blankestijn PJ; Doevendans PA; Bots ML; Vonken EJ; Voskuil M; Leiner T Eur J Prev Cardiol; 2015 May; 22(5):558-67. PubMed ID: 25326543 [TBL] [Abstract][Full Text] [Related]
6. Mid-Term Vascular Safety of Renal Denervation Assessed by Follow-up MR Imaging. Schmid A; Schmieder R; Lell M; Janka R; Veelken R; Schmieder RE; Uder M; Ott C Cardiovasc Intervent Radiol; 2016 Mar; 39(3):426-32. PubMed ID: 26253780 [TBL] [Abstract][Full Text] [Related]
8. The effect of renal denervation on kidney oxygenation as determined by BOLD MRI in patients with hypertension. Vink EE; Boer A; Verloop WL; Spiering W; Voskuil M; Vonken E; Hoogduin JM; Leiner T; Bots ML; Blankestijn PJ Eur Radiol; 2015 Jul; 25(7):1984-92. PubMed ID: 25595641 [TBL] [Abstract][Full Text] [Related]
9. Assessment of arterial stiffness to predict blood pressure response to renal sympathetic denervation. Fengler K; Rommel KP; Kriese W; Kresoja KP; Blazek S; Obradovic D; Feistritzer HJ; Lücke C; Gutberlet M; Desch S; Thiele H; Lurz P EuroIntervention; 2022 Oct; 18(8):e686-e694. PubMed ID: 35244604 [TBL] [Abstract][Full Text] [Related]
10. Renal denervation in moderate treatment-resistant hypertension. Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901 [TBL] [Abstract][Full Text] [Related]
11. Renal denervation for the treatment of hypertension: the Dutch consensus. Verloop WL; Agema WR; Allaart CP; Blankestijn PJ; Khan M; Meuwissen M; Muijs van de Moer WM; Rensing BJ; Spiering W; Voskuil M; Doevendans PA; Neth J Med; 2014 Nov; 72(9):449-54. PubMed ID: 25431389 [TBL] [Abstract][Full Text] [Related]
13. Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure. Fadl Elmula FE; Hoffmann P; Fossum E; Brekke M; Gjønnæss E; Hjørnholm U; Kjær VN; Rostrup M; Kjeldsen SE; Os I; Stenehjem AE; Høieggen A Hypertension; 2013 Sep; 62(3):526-32. PubMed ID: 23836798 [TBL] [Abstract][Full Text] [Related]
14. The cholinergic anti-inflammatory pathway in resistant hypertension treated with renal denervation. Hilderman M; Qureshi AR; Abtahi F; Witt N; Jägren C; Olbers J; Delle M; Lindecrantz K; Bruchfeld A Mol Med; 2019 Aug; 25(1):39. PubMed ID: 31416428 [TBL] [Abstract][Full Text] [Related]
15. Renal denervation in resistant hypertension: a review of clinical trials and future perspectives. Yamamoto E; Sueta D; Tsujita K Cardiovasc Interv Ther; 2022 Jul; 37(3):450-457. PubMed ID: 35474179 [TBL] [Abstract][Full Text] [Related]
16. Orthostatic function after renal sympathetic denervation in patients with resistant hypertension. Lenski M; Mahfoud F; Razouk A; Ukena C; Lenski D; Barth C; Linz D; Laufs U; Kindermann I; Böhm M Int J Cardiol; 2013 Nov; 169(6):418-24. PubMed ID: 24157238 [TBL] [Abstract][Full Text] [Related]
17. Renal Denervation in Asia: Consensus Statement of the Asia Renal Denervation Consortium. Kario K; Kim BK; Aoki J; Wong AY; Lee YH; Wongpraparut N; Nguyen QN; Ahmad WAW; Lim ST; Ong TK; Wang TD Hypertension; 2020 Mar; 75(3):590-602. PubMed ID: 32008432 [TBL] [Abstract][Full Text] [Related]
18. Renal sympathetic denervation for resistant hypertension--an alternate view. Das UN Med Hypotheses; 2013 Dec; 81(6):1135-6. PubMed ID: 24225122 [TBL] [Abstract][Full Text] [Related]
19. Renal denervation with cryoenergy as second-line option is effective in the treatment of resistant hypertension in non-responders to radiofrequency ablation. Prochnau D; Heymel S; Otto S; Figulla HR; Surber R EuroIntervention; 2014 Sep; 10(5):640-5. PubMed ID: 25256203 [TBL] [Abstract][Full Text] [Related]
20. Renal Denervation for Resistant Hypertension in the contemporary era: A Systematic Review and Meta-analysis. Agasthi P; Shipman J; Arsanjani R; Ashukem M; Girardo ME; Yerasi C; Venepally NR; Fortuin FD; Mookadam F Sci Rep; 2019 Apr; 9(1):6200. PubMed ID: 30996305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]